SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008331
Filing Date
2018-11-02
Accepted
2018-11-02 11:43:58
Documents
63
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20180930x10q.htm 10-Q 1645540
2 EX-31.1 imgn-20180930ex311a1635c.htm EX-31.1 11539
3 EX-31.2 imgn-20180930ex312893ae9.htm EX-31.2 11566
4 EX-32 imgn-20180930xex32.htm EX-32 10285
  Complete submission text file 0001558370-18-008331.txt   9853602

Data Files

Seq Description Document Type Size
5 EX-101.INS imgn-20180930.xml EX-101.INS 2609497
6 EX-101.SCH imgn-20180930.xsd EX-101.SCH 53708
7 EX-101.CAL imgn-20180930_cal.xml EX-101.CAL 43285
8 EX-101.DEF imgn-20180930_def.xml EX-101.DEF 331812
9 EX-101.LAB imgn-20180930_lab.xml EX-101.LAB 516834
10 EX-101.PRE imgn-20180930_pre.xml EX-101.PRE 506286
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 181156036
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1